DoD Says AVI Biopharma's (AVII) Flu Drug Candidate Does Not Qualify for Contract Award

Article Stock Quotes (1) Comments (0)

AVI Biopharma (Nasdaq: AVII) receives notice from Department of Defense its proposal for full clinical development of its influenza candidate, AVI-7100 did not qualify for a contract award.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Senate Takes Aim at Apple (AAPL); Says Irish Unit Earned $22B, Paid $10M in Taxes
• Sanofi (SNY), Regeneron (REGN) Report Publication of Positive Dupilumab Phase 2a Data
• Dell (DELL) Special Committee Sends Letter to Icahn, Southeastern

Create E-mail Alert Related Categories

Corporate News

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?